January 4, 2025 - 13:27

As 2024 unfolds, small businesses are increasingly concerned about the rising credit card swipe fees that continue to strain their operations. With many consumers opting for card payments over cash, the pressure on these businesses intensifies. The relentless increase in transaction fees has prompted a call to action from small business owners who are urging their customers to consider using cash for their purchases.
The landscape of payment methods is shifting, and while credit cards offer convenience, the associated costs can be burdensome for smaller retailers. These fees not only cut into profits but also create an uneven playing field against larger corporations that can absorb such costs more easily. In response, many small business owners are highlighting the benefits of cash transactions, including lower costs and faster processing times.
As the debate over swipe fees continues, the push for cash payments reflects a broader struggle for small businesses to maintain their viability in an increasingly cashless society. The future of payment methods remains uncertain, but the call for a return to cash is growing louder among those who feel the pinch of escalating fees.
November 16, 2025 - 02:27
Rochester's THC Edibles and Drinks Industry Faces Major SetbackNov. 15—ROCHESTER — The hemp-derived THC sector is facing a significant challenge following a recent federal decision that has left business owners reeling. A provision included in the...
November 15, 2025 - 01:13
Credicorp Optimistic About Growth in Bolivia Following New LeadershipFinancial conglomerate Credicorp Ltd expresses optimism about expanding its banking operations in Bolivia after the inauguration of President Rodrigo Paz. This significant political shift marks the...
November 14, 2025 - 00:20
Company Prepares for Phase 3 Trials in Chronic Cough TreatmentThe company has announced plans to initiate a comprehensive Phase 3 clinical program aimed at addressing chronic cough in patients suffering from idiopathic pulmonary fibrosis (IPF) in the first...
November 13, 2025 - 05:27
Savara Inc. Releases Financial Results for Q3 2025 and Business UpdateLANGHORNE, Pa., November 12, 2025—Savara Inc., a clinical stage biopharmaceutical company dedicated to addressing rare respiratory diseases, has announced its financial results for the third...